GB9515060D0 - Therapeutic heterocyclic compounds - Google Patents

Therapeutic heterocyclic compounds

Info

Publication number
GB9515060D0
GB9515060D0 GBGB9515060.3A GB9515060A GB9515060D0 GB 9515060 D0 GB9515060 D0 GB 9515060D0 GB 9515060 A GB9515060 A GB 9515060A GB 9515060 D0 GB9515060 D0 GB 9515060D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compounds
therapeutic heterocyclic
therapeutic
compounds
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9515060.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GBGB9515060.3A priority Critical patent/GB9515060D0/en
Publication of GB9515060D0 publication Critical patent/GB9515060D0/en
Priority to AU66581/96A priority patent/AU6658196A/en
Priority to JP9506303A priority patent/JPH11509537A/en
Priority to EP96926370A priority patent/EP0842173A1/en
Priority to PCT/EP1996/003188 priority patent/WO1997003983A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9515060.3A 1995-07-22 1995-07-22 Therapeutic heterocyclic compounds Pending GB9515060D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9515060.3A GB9515060D0 (en) 1995-07-22 1995-07-22 Therapeutic heterocyclic compounds
AU66581/96A AU6658196A (en) 1995-07-22 1996-07-19 4-{3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl}- 4(s)oxazolidin-2-one monobenzoate and sulphate salt
JP9506303A JPH11509537A (en) 1995-07-22 1996-07-19 4- [3- (trans-3-dimethylaminocyclobutyl) -1H-indol-5-ylmethyl] -4 (S) oxazolidin-2-one monobenzoate and sulfate
EP96926370A EP0842173A1 (en) 1995-07-22 1996-07-19 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl]-4(s)oxazolidin-2-one monobenzoate and sulphate salt
PCT/EP1996/003188 WO1997003983A1 (en) 1995-07-22 1996-07-19 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl]-4(s)oxazolidin-2-one monobenzoate and sulphate salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9515060.3A GB9515060D0 (en) 1995-07-22 1995-07-22 Therapeutic heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB9515060D0 true GB9515060D0 (en) 1995-09-20

Family

ID=10778112

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9515060.3A Pending GB9515060D0 (en) 1995-07-22 1995-07-22 Therapeutic heterocyclic compounds

Country Status (5)

Country Link
EP (1) EP0842173A1 (en)
JP (1) JPH11509537A (en)
AU (1) AU6658196A (en)
GB (1) GB9515060D0 (en)
WO (1) WO1997003983A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10426754B2 (en) * 2017-06-14 2019-10-01 Anavex Life Sciences Corp. Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98392A (en) * 1990-06-07 1996-01-19 Wellcome Found Indole derivatives their preparation and pharmaceutical compositions containing them
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds

Also Published As

Publication number Publication date
JPH11509537A (en) 1999-08-24
EP0842173A1 (en) 1998-05-20
AU6658196A (en) 1997-02-18
WO1997003983A1 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
EG24195A (en) Heterocyclic compounds
ZA9610020B (en) Heterocyclic compounds
GB9512697D0 (en) Heterocyclic compounds
GB9518552D0 (en) New heterocyclic compounds
PL322722A1 (en) Novel heterocyclic compounds
SG44926A1 (en) Therapeutic heterocyclic compounds
GB9504361D0 (en) Heterocyclic compounds
PL325637A1 (en) Novel heterocyclic compounds
GB9515060D0 (en) Therapeutic heterocyclic compounds
ZA962734B (en) Heterocyclic compounds
GB9509419D0 (en) Therapeutic heterocyclic compounds
GB9515305D0 (en) Therapeutic heterocyclic compounds
GB9521463D0 (en) Therapeutic heterocyclic compounds
GB9403905D0 (en) Therapeutic heterocyclic compounds
GB9608366D0 (en) Therapeutic heterocyclic compounds
GB9602740D0 (en) Therapeutic heterocyclic compounds
GB9512868D0 (en) Therapeutic compounds
GB9526110D0 (en) Therapeutic compounds
GB9523801D0 (en) Therapeutic compounds
GB9523558D0 (en) Therapeutic compounds
GB9305060D0 (en) Therapeutic heterocyclic compounds
GB9504839D0 (en) Heterocyclic compounds
GB9610149D0 (en) Heterocyclic compounds
GB9515302D0 (en) Heterocyclic compounds
ZA968551B (en) Heterocyclic compounds